Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCP Infrastructure Investments Regulatory News (GCP)

Share Price Information for GCP Infrastructure Investments (GCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.00
Bid: 77.00
Ask: 77.20
Change: -0.20 (-0.26%)
Spread: 0.20 (0.26%)
Open: 76.60
High: 77.15
Low: 76.60
Prev. Close: 77.20
GCP Live PriceLast checked at -
GCP Infrastructure Investments is an Investment Trust

To provide shareholders with regular, sustainable, long-term dividend income and to preserve the capital value of its investments over the long term by generating exposure to infrastructure debt and/or similar assets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Comment on Budget Statement

9 Jul 2015 14:16

RNS Number : 6481S
GCP Infrastructure Investments Ltd
09 July 2015
 



 

 

9 July 2015

 

GCP Infrastructure Investments Limited

("the Company")

Comment on Budget Statement

 

The Board of Directors of the Company has noted the Chancellor's statements in yesterday's Budget relating to the removal of the Climate Change Levy exemption for certain renewable energy projects from 1 August 2015.

Gravis Capital Partners LLP, the investment adviser to the Company, has conducted a preliminary review of the potential impact of these statements on the assets of the Company. It is the view of the Board, as advised by the investment adviser, that a minority (by value) of the projects against which the Company has provided debt will see a modest reduction in the forecast net cashflows available to service such debt during the period to 2022.

However, it is the opinion of the investment adviser that these reductions will not have a material impact on the ability of the projects to service such debt. As a result, it is the view of the Board, as advised by the investment adviser, that the cashflows expected to arise from the investments held by the Company will be wholly unaffected by the removal of the Climate Change Levy exemption.

Ian Reeves, the chairman of the Company, commented "The Company offers shareholders exposure to subordinated PFI debt and related assets including renewable energy. Its focus on investing in debt instruments ensures that the Company benefits from an element of protection whereby equity holders in investee projects suffer the first loss arising from any reduction in projects' free cash flows. In light of yesterday's announcement of a reduction in the level of public sector support for certain renewable energy projects, it is pleasing to see that the fundamentally conservative approach of the Company in providing debt to such projects leaves the Company essentially unaffected by that announcement".

 

Contact details:

 

Gravis Capital Partners LLP

 

Stephen Ellis

+44 (0)20 7518 1495

Rollo Wright

+44 (0)20 7518 1493

 Stifel Nicolaus Europe Limited

 

Neil Winward

+44 (0)20 7710 7600

Mark Bloomfield

 

Tunga Chigovanyika

 

Cenkos Securities

 

Dion Di Miceli

+44 (0)20 7397 1921

Tom Scrivens

+44 (0)20 7397 1915

Buchanan

 

Charles Ryland

+44 (0)20 7466 5000

Victoria Watkins

 

 

Notes to Editors

The Company

The Company is a closed-ended London Stock Exchange-listed investment company that seeks to generate returns from senior and subordinated infrastructure debt and related and/or similar assets. The Company is advised by Gravis Capital Partners LLP.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFLVDEIAIIE
Date   Source Headline
8th Jun 20219:47 amRNSAdditional Listing and Total Voting Rights
28th May 20219:23 amRNSAdditional Listing
13th May 20217:00 amRNSScrip Share Reference Price
30th Apr 20217:00 amRNSInvestor Report at 31 March 2021
21st Apr 202111:06 amRNSDividend Declaration & Scrip Dividend Alternative
19th Apr 20217:00 amRNSNet Asset Value(s)
31st Mar 20217:00 amRNSTotal Voting Rights
30th Mar 20217:00 amRNSRevolving Credit Facility
22nd Mar 20211:08 pmRNSNew Directorship Notification
12th Mar 20211:29 pmRNSHolding(s) in Company
9th Mar 20214:26 pmRNSDirector/PDMR Shareholding
9th Mar 20219:08 amRNSAdditional Listing and Total Voting Rights
26th Feb 20219:39 amRNSAdditional Listing
11th Feb 20217:00 amRNSScrip Share Reference Price
10th Feb 202112:50 pmRNSDirectorate Change
10th Feb 202112:49 pmRNSResult of AGM
27th Jan 20217:00 amRNSInvestor Report at 31 December 2020
22nd Jan 202111:54 amRNSDividend Declaration & Scrip Dividend Alternative
18th Jan 20217:00 amRNSNet Asset Value(s)
11th Jan 202110:31 amRNSUpdate research from QuotedData
8th Jan 20219:00 amRNSNotice of AGM Circular
31st Dec 20207:00 amRNSTotal Voting Rights
17th Dec 20207:00 amRNSAnnual report and financial statements
7th Dec 202012:37 pmRNSDirector/PDMR Shareholding
7th Dec 20209:13 amRNSAdditional Listing and Total Voting Rights
4th Dec 20207:00 amRNSInvestment Adviser strategic partnership
27th Nov 20207:00 amRNSAdditional Listing
12th Nov 20207:00 amRNSScrip Share Reference Price
30th Oct 20207:00 amRNSInvestor Report as at 30 September 2020
23rd Oct 202011:42 amRNSDividend Declaration & Scrip Dividend Alternative
23rd Oct 202010:41 amRNSDividend Declaration & Script Dividend Alternative
16th Oct 20207:00 amRNSNet Asset Value(s)
12th Oct 20207:00 amRNSGreen Economy Mark
3rd Sep 202012:50 pmRNSDirector/PDMR Shareholding
28th Aug 20209:56 amRNSAdditional Listing and Total Voting Rights
21st Aug 202012:54 pmRNSAdditional Listing
6th Aug 20207:00 amRNSScrip Share Reference Price
30th Jul 20207:00 amRNSInvestor Report as at 30 June 2020
28th Jul 20201:19 pmRNSNotification of Major Holdings
23rd Jul 202010:42 amRNSDividend Declaration & Scrip Dividend Alternative
15th Jul 20207:00 amRNSNet Asset Value(s)
30th Jun 20207:00 amRNSTotal Voting Rights
10th Jun 20205:35 pmRNSDirector/PDMR Shareholding
10th Jun 202012:04 pmRNSAdditional Listing and Total Voting Rights
3rd Jun 20207:00 amRNSAdditional Listing
1st Jun 20201:48 pmRNSUpdate research from QuotedData
29th May 20207:00 amRNSHalf-yearly Report and Financial Statements 2020
15th May 20207:00 amRNSScrip Share Reference Price
1st May 20207:00 amRNSInvestor Report as at 31 March 2020
24th Apr 202011:16 amRNSDividend Declaration & Scrip Dividend Alternative

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.